Megs Pharmaceutical Limited - Company Profile

It is a pharma public limited company based in Jaipur, Rajasthan, India, established in 2017.
2017 Jaipur, Rajasthan, India Active
Last Updated:
Access Report
About Megs Pharmaceutical Limited

Megs Pharmaceutical Limited, a active public limited company, was established on 03 August 2017 in Jaipur, Rajasthan, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U74999RJ2017PLC058722. Registered under ROC Roc Jaipur. it is unlisted. It has an authorized capital of ₹0.30 M and a paid-up capital of ₹0.30 M.

It upholds a compliant status. Its leadership includes Vijendra Singh Rathore (Director), Ray Singh (Director), Vrishdev Singh (Whole-Time Director). Past directors included Pushpendra Singh Shekhawat, Santosh Singh. It holds ₹3.80 M open charges and no settled loans. Its latest AGM occurred on 29 September 2024, with the balance sheet filed on 31 March 2024. It is based at P.No.D-82,Flat No.S-1, 2Nd Floor Manglam City, Vill-Hathoj, Jaipur, Rajasthan, 302012.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999RJ2017PLC058722

  • Registration Number

    058722

  • Incorporation Date

    03 August 2017

  • Authorized Capital

    ₹0.30 M

  • Paid-Up Capital

    ₹0.30 M

  • ROC Code

    Roc Jaipur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.30 M
  • Paid Up Capital ₹ 0.30 M
  • Company Age 8 Year, 6 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 3.80 M
  • Revenue Growth **** 46.43%
  • Profit Growth **** 51.14%
  • Ebitda **** 65.88%
  • Net Worth 9.51%
  • Total Assets **** 33.56%
Company report

Megs Pharmaceutical Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Megs Pharmaceutical Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Megs Pharmaceutical Limited?
Current Directors
Name Designation Appointment Date Status
Vijendra Singh Rathore Director 26 Jan 2020 Current
Ray Singh Director 03 Aug 2017 Current
Vrishdev Singh Whole-Time Director 03 Aug 2017 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Managing Director 04 Oct 2019 Past
Pramod Abcsdd Whole-Time Director 29 Jan 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Megs Pharmaceutical.

Megs Pharmaceutical Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 46.43% increase. The company also saw a substantial improvement in profitability, with a 51.14% increase in profit. The company's net worth moved up by a moderate rise of 9.51%.

Megs Pharmaceutical revenue growth over time
Megs Pharmaceutical profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 46.43%
*******
*******
*******
*******
Revenue from Operations
*******
 46.43%
*******
*******
*******
*******
Total Assets
*******
 33.56%
*******
*******
*******
*******
Profit or Loss
*******
 51.14%
*******
*******
*******
*******
Net Worth
*******
 9.51%
*******
*******
*******
*******
EBITDA
*******
 65.88%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Megs Pharmaceutical?

Unlock access to Megs Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹3,800,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 0.38 Cr
Latest Charge Details
Date Lender Amount Status
16 Dec 2023 Others ₹2.50 M Open
31 Jan 2022 Others ₹0.20 M Open
01 Sep 2021 Others ₹1.00 M Open
01 Sep 2021 Others ₹0.10 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Megs Pharmaceutical?

Unlock and access historical data on people associated with Megs Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Megs Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Megs Pharmaceutical's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Megs Pharmaceutical
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Megs Pharmaceutical Limited last Annual general meeting of members was held on 29 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Megs Pharmaceutical Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Jaipur. was completed.

  • Charges

    Progress on A charge with Others amounted to Rs. 2.50 M with Charge ID 100889910 was registered on 16 Dec 2023. was documented.

  • Charges

    A charge with Others amounted to Rs. 0.20 M with Charge ID 100538203 was registered on 31 Jan 2022. was recorded as a recent event.

  • Charges

    The activity A charge with Others amounted to Rs. 1.00 M with Charge ID 100476310 was registered on 01 Sep 2021. was completed.

  • Charges

    Progress on A charge with Others amounted to Rs. 0.10 M with Charge ID 100479818 was registered on 01 Sep 2021. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Megs Pharmaceutical Limited?

The CIN of Megs Pharmaceutical Limited is U74999RJ2017PLC058722.

Where is Megs Pharmaceutical Limited headquartered?

Megs Pharmaceutical Limited is headquartered at P.No.D-82,Flat No.S-1, 2Nd Floor Manglam City, Vill-Hathoj, Jaipur, Rajasthan, 302012.

When was Megs Pharmaceutical Limited incorporated?

Megs Pharmaceutical Limited was incorporated on 03 August 2017.

Who are the current directors of Megs Pharmaceutical Limited?

The current directors of Megs Pharmaceutical Limited are

What is the primary industry of Megs Pharmaceutical Limited?

The primary industry of Megs Pharmaceutical Limited is Pharma.

Is Megs Pharmaceutical Limited a listed company?

Megs Pharmaceutical Limited is unlisted.

What is the capital structure of Megs Pharmaceutical Limited?

The authorized capital of Megs Pharmaceutical Limited is ₹0.30 M, and the paid-up capital is ₹0.30 M.

What is the compliance status of Megs Pharmaceutical Limited?

The compliance status of Megs Pharmaceutical Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available